DUBLIN--(BUSINESS WIRE)--The "8th Annual Biomarker and Companion Diagnostics Conference" conference has been added to ResearchAndMarkets.com's offering.
'8th Annual Biomarker and Companion Diagnostics Conference'
Leveraging next-gen technologies beyond conventional biomarker drug discovery!
The hosts bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.
30+ experts from academia and industry will be presenting their current work in Biomarkers, the latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, the Impact of Big data in translational biomarker research and the Future of Companion Diagnostics Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.
Over 20 presentations, round tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.
The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases. Attendees would evidence the examples and the case studies which will help in creating the revenue. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers. Biomarker Drug Discovery and Assay Development
Multiplex Companion Diagnostics and Regulatory Guidelines
Design of clinical trials in CDx
Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases
Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:
Biomarker discovery/development
Biomarkers in Clinical Discovery
Immuno-oncology/Neuroscience Drug Discovery
Diagnostic Biomarkers development
Opening Remarks from the Chairman
Challenges associated with Clinical Biomarker Validation
Solution Provider Presentation-Reserved for Gold Sponsor
Morning Refreshments and Poster Presentation - One-to-One Networking Meetings
Non-invasive biomarker identification and analysis using Breath Biopsy
11:10 - 11:40 Huw Davies, VP, Global Sales, Owlstone Medical
Studying the clinical change of paradigm in liquid biopsies
Use of biomarkers in clinics-success and challenges of getting a good biomarker
Lunch and Poster Presentation - One-to-One Networking Meetings
Role of Biomarkers in Personalized Medicine
Precision Oncology Centric Development of Antibody Drug Conjugates
14:10 - 14:40 Rakesh Dixit, CEO, Bionavigen
Why is monitoring predictive biomarker data so difficult for big pharma?
AI for proteomics and biomarker discovery
Afternoon Refreshments and Poster Presentation - One-to-One Networking Meetings
Patient Identification and Stratification applying predictive models
Use of Real World Evidence in the discovery of digital biomarkers
Closing Remarks from the Chairman
Opening Remarks from the Chairman
From Biomarkers to CDx: Strategies to accelerate CDx development and Commercialization Solution Provider Presentation-Reserved for Gold Sponsor
Morning Refreshments and Poster Presentation - One-to-One Networking Meetings
Future of RNA Diagnostics in Cancer CDx Launch Success: From Early Biomarker Development to Commercialization
Building up a successful CDx partnership with Pharma Lunch and Poster Presentation - One-to-One Networking Meetings
Leveraging IO markers for companion diagnostics development
Innovative Safety Biomarker Applications to Drug Development
For more information about this conference visit https://www.researchandmarkets.com/r/lwpsu7